ADMA BIOLOGICS, INC. Class of Warrant or Right, Outstanding
ADMA BIOLOGICS, INC. (ADMA) had Class of Warrant or Right, Outstanding of 38.10 million shares as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2025-11-05
- 2025-09-30: Class of Warrant or Right, Outstanding 38.10M shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 37.50M shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 36.62M shares.
- 2024-09-30: Class of Warrant or Right, Outstanding 27.76M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2025-09-30 | 38.10M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 37.50M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 36.62M shares 10-Q · filed 2025-05-07 |
| 2024-09-30 | 27.76M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 31.41M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 33.60M shares 10-Q · filed 2024-05-09 |
| 2023-09-30 | 43.09M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 46.94M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 48.36M shares 10-Q · filed 2023-05-10 |
| 2022-09-30 | 49.95M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 50.52M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 32.81M shares 10-Q · filed 2022-05-11 |
| 2021-09-30 | 16.83M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 17.07M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 17.08M shares 10-Q · filed 2021-05-12 |
| 2020-12-31 | 4.53M shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 2.14M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 2.14M shares 10-Q · filed 2020-08-05 |
| 2019-12-31 | 2.14M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |